Concord Medical Services ... (CCM)
NYSE: CCM
· Real-Time Price · USD
5.19
-0.10 (-1.89%)
At close: Aug 15, 2025, 3:33 PM
5.19
0.00%
After-hours: Aug 15, 2025, 02:24 PM EDT
Concord Medical Services Income Statement
Financials in CNY. Fiscal
year is
January - December.
| Fiscal Year | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 471.7M | 504.55M | 537.4M | 574.87M | 612.34M | 542.21M | 472.08M | 454.55M | 437.01M | 461.32M | 485.63M | 409.26M | 332.89M | 277.95M |
Cost of Revenue | 552.48M | 583.25M | 614.01M | 663.72M | 713.43M | 668.96M | 624.49M | 604.76M | 585.02M | 563.77M | 542.53M | 428.24M | 313.95M | 261.94M |
Gross Profit | -80.78M | -78.69M | -76.61M | -88.85M | -101.1M | -126.75M | -152.41M | -150.21M | -148.01M | -102.45M | -56.9M | -18.98M | 18.93M | 16.01M |
Operating Income | -874.75M | -668.87M | -462.99M | -509.81M | -556.64M | -786.46M | -1.02B | -768.15M | -520.03M | -489.17M | -458.32M | -399.13M | -339.94M | -327.97M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -659.22M | -607.4M | -555.59M | -678.7M | -801.8M | -820.85M | -839.9M | -731.99M | -624.07M | -576.66M | -529.24M | -491.89M | -454.55M | -448.1M |
Net Income | -378.93M | -338.29M | -297.66M | -381.83M | -465.99M | -477.83M | -489.66M | -392.7M | -295.75M | -283.59M | -271.43M | -271.48M | -271.52M | -290.76M |
Selling & General & Admin | 365.92M | 376.15M | 386.38M | 389.37M | 392.36M | 382.5M | 372.64M | 372.33M | 372.01M | 386.72M | 401.42M | 375.9M | 350.38M | 335.48M |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | 428.05M | 214.03M | n/a | 31.59M | 63.18M | 277.21M | 491.23M | 245.62M | n/a | n/a | n/a | 4.25M | 8.5M | 8.5M |
Operating Expenses | 793.97M | 590.17M | 386.38M | 420.96M | 455.54M | 659.71M | 863.87M | 617.94M | 372.01M | 386.72M | 401.42M | 380.15M | 358.88M | 343.98M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | 54.91M | 55.61M | 56.3M | 58.86M | 61.42M | 61.45M | 61.48M | 63.95M | 66.43M | 60.05M | 53.67M | 35.5M | 17.33M | 21.55M |
Cost & Expenses | 1.35B | 1.17B | 1B | 1.08B | 1.17B | 1.33B | 1.49B | 1.22B | 957.03M | 950.49M | 943.95M | 808.39M | 672.83M | 605.92M |
Income Tax Expense | 9.83M | 17.2M | 24.57M | 54.61M | 84.65M | 77.78M | 70.91M | 40.91M | 10.91M | 8.74M | 6.57M | 25.68M | 44.79M | 43.04M |
Shares Outstanding (Basic) | 145.6K | 145.6K | 145.23K | 145.23K | 145.6K | 145.6K | 145.37K | 145.37K | 145.6K | 145.6K | 36.1K | 36.1K | 39.67K | 39.67K |
Shares Outstanding (Diluted) | 145.6K | 145.6K | 145.6K | 145.6K | 145.6K | 145.6K | 145.6K | 145.6K | 145.6K | 145.6K | 145.6K | 145.6K | 145.6K | 145.6K |
EPS (Basic) | -2.6K | -2.32K | -2.04K | -2.62K | -3.2K | -3.28K | -3.36K | -4.58K | -5.8K | -5.72K | -5.64K | -4.97K | -4.31K | -4.45K |
EPS (Diluted) | -2.61K | -2.33K | -2.05K | -2.63K | -3.2K | -3.29K | -3.37K | -4.58K | -5.8K | -6.55K | -7.29K | -6.63K | -5.97K | -5.83K |
EBITDA | -326.79M | -333.84M | -340.89M | -355.03M | -377.45M | -400.43M | -423.41M | -428.08M | -431.49M | -406.55M | -381.61M | -324.1M | -264.27M | -255.9M |
EBIT | -446.7M | -454.84M | -462.99M | -478.22M | -493.46M | -509.25M | -525.05M | -522.54M | -520.03M | -489.17M | -458.32M | -394.88M | -331.44M | -319.47M |
Depreciation & Amortization | 119.92M | 121.01M | 122.1M | 123.19M | 116M | 108.82M | 101.64M | 94.46M | 88.54M | 82.62M | 76.7M | 70.79M | 67.18M | 63.57M |